报告题目：Translating microRNA pharmacoepigenetics into therapy
报 告 人：喻爱明，博士，副教授（生物化学与分子医学系，University of California, Davis）
报告时间：2016年12月12日（周一）下午2：00
报告地点：独墅湖校区二期药学院1323室
Dr. Aiming Yu is an Associate Professor of Biochemistry and Molecular Medicine at University of California, Davis (UCD). Dr. Yu obtained his Ph.D. from Nankai University in Tianjin, China in 1998. He then worked at University of Washington (Seattle, WA) and West Virginia University (Morgantown, WV) as a postdoctoral research associate, and National Cancer Institute (Bethesda, MD) as a research fellow. Dr. Yu’s research interests include noncoding RNA epigenetics, pharmacogenetics, and cancer therapy. The ultimate goal of their research is to define the mechanistic functions of noncoding RNAs such as microRNAs in the control of cancer cellular processes such as drug disposition and tumor progression, and to develop novel noncoding RNA-based therapies. Currently, efforts in his laboratory are directed to the investigation of (a) the roles of noncoding RNAs in the regulation of cytochrome P450 drug-metabolizing enzymes, ATP-binding cassette transporters and oncogenes, and (b) noncoding RNA-based cancer therapeutics.
Dr. Yu also directs the PK/PD Bioanalytical Laboratory at UC Davis, which is aimed at providing state-of-the-art bioanalytical services in support of the clinical and preclinical drug development programs.
E-mail: aimyu@ucdavis.edu
